Key statistics
As of last trade, Immunovia AB (publ) (1YR:BER) traded at 0.0752, 3,586.27% above the 52 week low of 0.002 set on Oct 31, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.0833 |
---|---|
High | 0.0833 |
Low | 0.0638 |
Bid | 0.0337 |
Offer | 0.1168 |
Previous close | 0.0833 |
Average volume | 0.00 |
---|---|
Shares outstanding | 169.71m |
Free float | 143.15m |
P/E (TTM) | -- |
Market cap | 128.98m SEK |
EPS (TTM) | -1.30 SEK |
Data delayed at least 15 minutes, as of Oct 08 2024 18:35 BST.
More ▼
Press releases
- Immunovia has successfully acquired all blood samples required to clinically validate its next-generation test for pancreatic cancer
- Immunovia completes analytical validation of its next-generation pancreatic cancer test
- Change in number of shares and votes in Immunovia AB (publ)
- Immunovia presents data from model development study at 2024 AACR Advances in Pancreatic Cancer medical conference
- Immunovia Publishes Interim Report for January-June 2024
- Immunovia's next-generation test to be included in large study of pancreatic cysts funded by the U.S. National Institutes of Health
- Immunovia files US patent application to protect its next-generation test
- Immunovia completes development of its pancreatic cancer detection test after substantially increasing test accuracy
- Invitation to Immunovia's Q2 presentation
- Immunovia presents data from discovery study at 2024 PancreasFest medical conference
More ▼